These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38447883)

  • 1. EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer.
    Li Z; Liu Q; Cai Y; Ye N; He Z; Yao Y; Ding Y; Wang P; Qi C; Zheng L; Wang L; Zhou J; Zhang QQ
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167114. PubMed ID: 38447883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling.
    Namkoong S; Kim CK; Cho YL; Kim JH; Lee H; Ha KS; Choe J; Kim PH; Won MH; Kwon YG; Shim EB; Kim YM
    Cell Signal; 2009 Jun; 21(6):906-15. PubMed ID: 19385062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cAMP regulated EPAC1 supports microvascular density, angiogenic and metastatic properties in a model of triple negative breast cancer.
    Kumar N; Prasad P; Jash E; Jayasundar S; Singh I; Alam N; Murmu N; Somashekhar SP; Goldman A; Sehrawat S
    Carcinogenesis; 2018 Oct; 39(10):1245-1253. PubMed ID: 29982410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation.
    Garg J; Feng YX; Jansen SR; Friedrich J; Lezoualc'h F; Schmidt M; Wieland T
    Oncotarget; 2017 Jul; 8(27):44732-44748. PubMed ID: 28512254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth.
    Lin Y; Zhao Y; Chen M; Li Z; Liu Q; Chen J; Ding Y; Ding C; Ding Y; Qi C; Zheng L; Li J; Zhang R; Zhou J; Wang L; Zhang QQ
    BMC Cancer; 2023 May; 23(1):479. PubMed ID: 37237269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers.
    Di Mauro C; Rosa R; D'Amato V; Ciciola P; Servetto A; Marciano R; Orsini RC; Formisano L; De Falco S; Cicatiello V; Di Bonito M; Cantile M; Collina F; Chambery A; Veneziani BM; De Placido S; Bianco R
    Br J Cancer; 2017 May; 116(11):1425-1435. PubMed ID: 28441382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling.
    Liu H; Mei FC; Yang W; Wang H; Wong E; Cai J; Toth E; Luo P; Li YM; Zhang W; Cheng X
    Sci Adv; 2020 Jan; 6(1):eaay3566. PubMed ID: 31911948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.
    Zhang X; Zou G; Li X; Wang L; Xie T; Zhao J; Wang L; Jiao S; Xiang R; Ye H; Shi Y
    Cancer Biol Med; 2020 Aug; 17(3):693-706. PubMed ID: 32944400
    [No Abstract]   [Full Text] [Related]  

  • 9. The epigallocatechin gallate derivative Y
    Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
    J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.
    Shin SU; Cho HM; Das R; Gil-Henn H; Ramakrishnan S; Al Bayati A; Carroll SF; Zhang Y; Sankar AP; Elledge C; Pimentel A; Blonska M; Rosenblatt JD
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
    Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling.
    Huang Y; Fang J; Lu W; Wang Z; Wang Q; Hou Y; Jiang X; Reizes O; Lathia J; Nussinov R; Eng C; Cheng F
    Cell Chem Biol; 2019 Aug; 26(8):1143-1158.e6. PubMed ID: 31178408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel VEGF receptor 2 inhibitor YLL545 inhibits angiogenesis and growth in breast cancer.
    Zhang J; Liu C; Shi W; Yang L; Zhang Q; Cui J; Fang Y; Li Y; Ren G; Yang S; Xiang R
    Oncotarget; 2016 Jul; 7(27):41067-41080. PubMed ID: 27203384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via inhibition of the CUX1/FGF1/HGF signalling pathway.
    Chen J; Zhou Z; Yao Y; Dai J; Zhou D; Wang L; Zhang QQ
    J Cell Mol Med; 2018 Oct; 22(10):4760-4770. PubMed ID: 30010249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
    Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
    J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells.
    Jiang F; Li Y; Si L; Zhang Z; Li Z
    Cell Biol Toxicol; 2019 Aug; 35(4):361-371. PubMed ID: 30612216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling.
    Chang CH; Ou TT; Yang MY; Huang CC; Wang CJ
    J Ethnopharmacol; 2016 Jul; 188():111-22. PubMed ID: 27178635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular receptor EPAC regulates von Willebrand factor secretion from endothelial cells in a PI3K-/eNOS-dependent manner during inflammation.
    Xiao J; Zhang B; Su Z; Liu Y; Shelite TR; Chang Q; Qiu Y; Bei J; Wang P; Bukreyev A; Soong L; Jin Y; Ksiazek T; Gaitas A; Rossi SL; Zhou J; Laposata M; Saito TB; Gong B
    J Biol Chem; 2021 Nov; 297(5):101315. PubMed ID: 34678311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decylubiquinone suppresses breast cancer growth and metastasis by inhibiting angiogenesis via the ROS/p53/ BAI1 signaling pathway.
    Cao J; Liu X; Yang Y; Wei B; Li Q; Mao G; He Y; Li Y; Zheng L; Zhang Q; Li J; Wang L; Qi C
    Angiogenesis; 2020 Aug; 23(3):325-338. PubMed ID: 32020421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.